EP2985031
USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.6.2009EP published:
12.4.2017EP application number:
15000994.2
EPO information:
European Patent Register
Max expiry date:
1.6.2029
Title:
USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
Timeline
Today
2.6.2009EP application
12.4.2017EP Publication
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
Inventor
Name:
Bonny, ChristopheAddress:
Avenches, CH
Priority
Number:
PCT/EP2008/004341Date:
30.5.2008Country:
WO
Classification
Categories:
A61K 38/01, A61K 38/03, A61K 38/04, A61P 9/00, A61P 11/00, A61P 17/00, A61P 25/00, A61P 31/12, A61P 37/00